You are here: Industry Insights > Roche

News List

Avastin wins full green light for glioblastoma pharmatimes
December 08, 2017
Roche group Genentech has announced full US approval for Avastin for the treatment of adults with glioblastoma that progressed following prior therapy.
Roche’s Tecentriq available via CDF pharmatimes
December 08, 2017
Roche’s Tecentriq will be available on the NHS in England via the Cancer Drugs Fund for certain patients with metastatic urothelial carcinoma.
Roche's haemophilia A drug shows meaningful bleed control in P3 pharmafile
December 08, 2017
Roche Has New Phase 3 Clinical Trial of Hemophilia A for Helimbra (emicizumab) for Patients Under 12
Roche links with UK gov on digital pathology services pharmatimes
December 07, 2017
The UK Government is in discussions with Roche Diagnostics and partners to support the mainstream implementation of digital pathology services across the NHS.
FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic pro roche
December 05, 2017
Roche Corporation announced today that the FDA has approved the FoundationOne CDx ™ Foundation's comprehensive companion diagnostic method for personalized oncology treatment1
Roche launches fully integrated and streamlined NGS sample prep solution pharmaasia
December 01, 2017
The new Roche sample prep solution is complete, less complex, easy-to-use and automation friendly, enabling researchers to proceed with less hassle.
Roche’s Erivedge no longer be financed on the NHS as skin cancer treament pharmatimes.
November 24, 2017
Roche’s Erivedge will indeed no longer be funded on the National Health Service as a treatment for skin cancer after cost regulators issued final guidance ruling that it is not cost effective.
Roche’s Hemlibra reduces bleeds in haemophilia A patients pharmatimes
November 21, 2017
Roche’s Hemlibra has hit key targets in a Phase III trial assessing its effectiveness in preventing bleeds in adults and adolescents with haemophilia A without inhibitors to factor VIII.
Roche to acquire Viewics, Inc. to provide data-driven lab business analytics and add further digital worldpharmanews
November 21, 2017
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics.
Roche's hep A treatment gets nod but with black box warning pharmafile
November 20, 2017
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, as the FDA approves its hepatitis A medicine, it looks like it may be delivering.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page